Vendor review
ZLZ Peptide reviews
ZLZ Peptide reviews from 309 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is ZLZ Peptide legit? See what its vials showed.
What the lab tests show
309 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 12, 2026 | Retatrutide | 98.9 % | 18.2 mg of 20 mg (-9 %) | Pass | View |
| Oct 12, 2026 | Tirzepatide | 99.9 % | 137 mg of 120 mg (14 %) | Pass | View |
| Oct 8, 2026 | Retatrutide | 99.9 % | 20.6 mg of 20 mg (3 %) | Pass | View |
| Oct 6, 2026 | Retatrutide | 99.9 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| Oct 6, 2026 | NAD+ | 99.9 % | 1567.2 mg of 500 mg (213 %) | Pass | View |
| Oct 1, 2026 | Semaglutide | 98.9 % | 17.2 mg of 15 mg (15 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.99 % | 22.71 mg of 20 mg (14 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.9 % | 9.99 mg of 10 mg (0 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.8 % | 15.5 mg of 15 mg (3 %) | Pass | View |
| Sep 24, 2026 | Tirzepatide | 40.4 % | 6.06 mg of 15 mg (-60 %) | Pass | View |
| Sep 24, 2026 | NAD+ | 98.3 % | 653 mg of 1000 mg (-35 %) | Pass | View |
| Sep 23, 2026 | Retatrutide | 99.9 % | 19.8 mg of 20 mg (-1 %) | Pass | View |
| Sep 21, 2026 | Tirzepatide | 100 % | 30.3 mg of 30 mg (1 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 55.9 mg of 50 mg (12 %) | Pass | View |
| Sep 8, 2026 | Retatrutide | 99.9 % | 23.1 mg of 20 mg (16 %) | Pass | View |
| Sep 5, 2026 | Semaglutide | 99.9 % | 25.2 mg of 30 mg (-16 %) | Pass | View |
| Sep 4, 2026 | Retatrutide | 99.9 % | 4.12 mg of 5.01 mg (-18 %) | Pass | View |
| Sep 4, 2026 | Tesamorelin | 99.9 % | 4.16 mg of 5 mg (-17 %) | Pass | View |
| Aug 25, 2026 | Retatrutide | 99.8 % | 22.1 mg of 20 mg (11 %) | Pass | View |
| Aug 21, 2026 | Tirzepatide | 99.9 % | 127.4 mg of 120 mg (6 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.9 % | 26.4 mg of 30 mg (-12 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 20.2 mg of 20 mg (1 %) | Pass | View |
| Aug 9, 2026 | PT-141 | 99.8 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Aug 6, 2026 | GHK-Cu | 99.7 % | 89 mg of 100 mg (-11 %) | Pass | View |
| Aug 6, 2026 | Tesamorelin | 99.8 % | 22.1 mg of 20 mg (11 %) | Pass | View |
| Aug 5, 2026 | Tirzepatide | 99.7 % | 50.7 mg of 60 mg (-16 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 18.9 mg of 20 mg (-6 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 27.5 mg of 30 mg (-8 %) | Pass | View |
| Jul 23, 2026 | Tesamorelin | 99 % | 9.66 mg of 10 mg (-3 %) | Pass | View |
| Jul 23, 2026 | GHK-Cu | 99.9 % | 45.5 mg of 50 mg (-9 %) | Pass | View |
| Jul 23, 2026 | BPC-157 | 99.7 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jul 15, 2026 | BPC-157 | 99 % | 12 mg of 10 mg (20 %) | Pass | View |
| Jul 15, 2026 | TB-500 | 99.8 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Jul 15, 2026 | GHK-Cu | 99.7 % | 70.3 mg of 50 mg (41 %) | Pass | View |
| Jul 15, 2026 | Sermorelin | 99.5 % | 4.9 mg of 5 mg (-2 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 9.66 mg of 10 mg (-3 %) | Pass | View |
| Jul 13, 2026 | NAD+ | 99.2 % | 435 mg of 500 mg (-13 %) | Pass | View |
| Jul 10, 2026 | Tirzepatide | 99.9 % | 21.7 mg of 20 mg (9 %) | Pass | View |
| Jul 10, 2026 | Retatrutide | 99.9 % | 42.2 mg of 40 mg (6 %) | Pass | View |
| Jul 1, 2026 | Semaglutide | 99.9 % | 6.72 mg of 5 mg (34 %) | Pass | View |
| Jul 1, 2026 | Tirzepatide | 99.9 % | 41.3 mg of 40 mg (3 %) | Pass | View |
| Jul 1, 2026 | GHK-Cu | 99.9 % | 87.1 mg of 100 mg (-13 %) | Pass | View |
| Jun 26, 2026 | Retatrutide | 99.6 % | 29.9 mg of 30 mg (0 %) | Pass | View |
| Jun 24, 2026 | Tesamorelin | 98.3 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Jun 24, 2026 | Tesamorelin | 99.4 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jun 24, 2026 | Retatrutide | 99.9 % | 18.9 mg of 20 mg (-6 %) | Pass | View |
| Jun 24, 2026 | Retatrutide | 99.9 % | 9.45 mg of 10 mg (-6 %) | Pass | View |
| Jun 23, 2026 | NAD+ | 98.5 % | 1230 mg of 1000 mg (23 %) | Pass | View |
| Jun 15, 2026 | Tirzepatide | 99.9 % | 27.6 mg of 30 mg (-8 %) | Pass | View |
| Jun 15, 2026 | Tirzepatide | 99.9 % | 35.6 mg of 40 mg (-11 %) | Pass | View |
| Jun 15, 2026 | Retatrutide | 99.9 % | 27.9 mg of 30 mg (-7 %) | Pass | View |
| Jun 12, 2026 | Tirzepatide | 99.8 % | 49.2 mg of 40 mg (23 %) | Pass | View |
| May 20, 2026 | Tesamorelin | 99.9 % | 23.8 mg of 20 mg (19 %) | Pass | View |
| May 13, 2026 | BPC-157 | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| May 13, 2026 | TB-500 | 99.3 % | 2.06 mg of 2 mg (3 %) | Pass | View |
| May 13, 2026 | Semaglutide | 99.9 % | 5.81 mg of 10 mg (-42 %) | Pass | View |
| May 13, 2026 | Retatrutide | 99.9 % | 16.3 mg of 15 mg (9 %) | Pass | View |
| May 13, 2026 | NAD+ | 98.5 % | 594 mg of 1000 mg (-41 %) | Pass | View |
| May 11, 2026 | Tirzepatide | 99.9 % | 41.5 mg of 40 mg (4 %) | Pass | View |
| May 11, 2026 | Tirzepatide | 99.9 % | 55.4 mg of 60 mg (-8 %) | Pass | View |
What ZLZ Peptide sells
No current listings on record.
About ZLZ Peptide
Finnrick has tested 309 samples from ZLZ Peptide across 14 products.